NEW Left to Our Own Devices episode: #HRStv host @OliverMonfredi chats with @Nicky_P_MD about the management of vegetations around the time of lead extraction. They discuss when and how to aspirate vegetations and review a real-world case highlighting a successful vegetation aspiration. See the full interview here #EPeeps ➡️ https://t.co/l3xpHVVAlQ
I agree with @naijaQRS I feel like this just supports what's already happening.... low risk, no/low burden pts are often taken off AC post successful ablation.
For me these are and will continue to be an individualized decision - candid discussion with patients, review of available literature and recommendations and ultimately shared decision making
#Afib
# EPeeps
It was a redo, atypical AFL, we got catheters up and mapped the RA first, exchanged for the dilator and Versacross wire in SVC - noticed it right before going transeptal.
Last dose of OAC was previous evening
Received heparin
We Aspirated through the sheath
Did not go left sided
Ablated the CTI (partially reconnected) and bicaval scar
We mapped with Octaray and were using the faradrive sheath ????? Small catheter in a larger sheath (this has been reported with the Versacross Kinect for Watchman and pigtail)
💙 This #NursesWeek, HRS celebrates The Power of Nurses—including 1,200 HRS members who advance the field of electrophysiology from the front lines of care to the forefront of innovation.
We see you. We support you. We honor you. 👏
#ThePowerOfNurses#EPeeps#NationalNursesWeek
Standing room only! Amazing update from Dr. Niraj Varma on the INTEGRA-D clinical trial. Thank you Dr. Panico and Heart Rhythm TV!
Disclaimer: CCM-D is an investigational device and is not approved for commercial use in the U.S.
Heart Rhythm TV Update: Cardiac Contractility Modulation with Defibrilla... https://t.co/XMIYgzwWra via @YouTube
205 patients from 15 US centers that underwent cardioneural ablation with 78% freedom from recurrent syncope and 97% freedom from pacemakers.
Simpub in @JACCJournals
https://t.co/6J8kaWePtm
@naijaQRS you and I are on the same page (no surprise there) - sometimes less is more.
We need to be mindful of this data - which may change how we select the right technology/procedure for the right patient… and certainly PW for all is not likely the answer!!
The most important data out of this past weekend for me was the NEMESIS-PFA study. PFA causes extensive collateral damage and LA dysfunction compared to RF. More ablation isn’t better. @AZ_EP_DOC#HRS2025#EPeeps